Romi Bhasin, M.D., PhD., F.A.C.E.

Columbus Endocrinology

Specialties

Endocrinology, Internal Medicine

Accepting New Patients

Yes

Gender

Male

Languages Spoken

Hindi, English

Other Information

Areas of Interest

  • Endocrinology

Associations & Organizations

  • Member, Alpha Omega Alpha honor society (AOA)
  • Elected member, Association of Pathology Chairs Honor Society
  • Research Award, Asians in Medicine (AIM), S.U.N.Y.

Publications

  • Bhasin, R., Arce, F.C. and Pasmantier, R. “ Hypoglycemia associated with Use of gatifloxacin” Amer. J. Med. Sci. 330/5, 250-253 (2005).
  • Arce, F.C., Bhasin, R., and Pasmantier, R. “ Severe Hyperglycemia in Non-diabetic patients receiving Gatifloxacin.” Endocrine Practice 10(1), 40-44 (2004).
  • Bhasin, R., Gregori, L., Morozov, I., and Goldgaber, D. “ A Processing Pathway for Amyloid Beta Protein Precursor Generates a Secreted Form With an Intact Carboxyl Terminus.” Amyloid: J.exp. Clin. Invest. 1, 221-231 (1994).
  • Gregori, L., Bhasin, R., and Goldgaber, D. “ Ubiquitin-mediated degradation pathway degrades the extracellular but not the intracellular form of amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 203 (3), 1731-1738, (1994).
  • Schwarzman, A.L., Gregori, L., Vitek, M.P., Lyubski, S., Stritmatter, W.J., Enghilde, J.J., Bhasin, R., Silverman, J., Weigraber, K.H., Coyle, P.K., et. al. “Transthyretin sequesters amyloid beta protein precursor and prevents amyloid formation.” Proc. Natl. Acad. Sci. (USA) 91 (18), 8368-8372.
  • Goldgaber, D., Schwarzman, A.L., Bhasin, R., Gregori, L., Schemchel, D., Saunders, A.M., Roses, A.D., and Stritmatter, W.J. “Sequestration of amyloid beta peptide.” Annals of the New York Academy of Sciences, 695, 139-143, (1993).
  • Stritmatter, W.J., Huang, D.Y., Bhasin, R., Roses, A.D. and Goldgaber, D. “Avid binding of beta amyloid to it’s own precursor.” Exp. Neurol. 122(2), 327-334, (1993).

Previous Organizations & Titles

  • Private Practice in Endocrinology
  • Contract Physician, VA
  • Contract Physician, Emergency Room, VA

Medical School

M.D., S.U.N.Y., Stony Brook, NY

Board Certification

American Board of Internal Medicine Endocrinology and Metabolism American Board of Internal Medicine

Insurances Accepted

  • Access Health Fairfield

  • Aetna

  • Aetna Better Health aka Aetna MyCare

  • Aetna Medicare (COPC Senior Care Advantage Participant)

  • Anthem Blue Cross Blue Shield

  • BCMH

  • Caresource Market Exchange

  • Cigna

  • Coventry-First Health

  • HealthSmart

  • Humana Commercial

  • Humana Medicare (COPC Senior Care Advantage Participant)

  • Medicaid

  • Medical Mutual of Ohio (MMO)

  • Medicare

  • MediGold (COPC Senior Care Advantage Participant)

  • MediShare Plans

  • Meritain

  • MMO OhioHealth HMO

  • Molina Medicaid - Established Patients Only

  • Mt. Carmel Health Partners Trinity Health Plan

  • Multiplan

  • Ohio Health Choice (OHCP)

  • OhioHealthy

  • OSCAR Buckeye Health

  • OSU Health Plans

  • PHCS

  • PPO Connect

  • Railroad Medicare

  • Tricare Prime Remote-PCP Network Plan

  • Tricare Standard

  • Trinity Health Plan - Aetna Administered

  • UMWA

  • UnitedHealthcare

Central Ohio Primary Care Logo

Romi Bhasin, M.D., PhD., F.A.C.E.

Columbus Endocrinology

Gender

Male

Specialties

Endocrinology, Internal Medicine

Medical School

M.D., S.U.N.Y., Stony Brook, NY

Board Certification

American Board of Internal Medicine Endocrinology and Metabolism American Board of Internal Medicine

Languages Spoken

Hindi, English

Accepting New Patients

Yes

Associations & Organizations
  • Member, Alpha Omega Alpha honor society (AOA)
  • Elected member, Association of Pathology Chairs Honor Society
  • Research Award, Asians in Medicine (AIM), S.U.N.Y.


Publications
  • Bhasin, R., Arce, F.C. and Pasmantier, R. “ Hypoglycemia associated with Use of gatifloxacin” Amer. J. Med. Sci. 330/5, 250-253 (2005).
  • Arce, F.C., Bhasin, R., and Pasmantier, R. “ Severe Hyperglycemia in Non-diabetic patients receiving Gatifloxacin.” Endocrine Practice 10(1), 40-44 (2004).
  • Bhasin, R., Gregori, L., Morozov, I., and Goldgaber, D. “ A Processing Pathway for Amyloid Beta Protein Precursor Generates a Secreted Form With an Intact Carboxyl Terminus.” Amyloid: J.exp. Clin. Invest. 1, 221-231 (1994).
  • Gregori, L., Bhasin, R., and Goldgaber, D. “ Ubiquitin-mediated degradation pathway degrades the extracellular but not the intracellular form of amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 203 (3), 1731-1738, (1994).
  • Schwarzman, A.L., Gregori, L., Vitek, M.P., Lyubski, S., Stritmatter, W.J., Enghilde, J.J., Bhasin, R., Silverman, J., Weigraber, K.H., Coyle, P.K., et. al. “Transthyretin sequesters amyloid beta protein precursor and prevents amyloid formation.” Proc. Natl. Acad. Sci. (USA) 91 (18), 8368-8372.
  • Goldgaber, D., Schwarzman, A.L., Bhasin, R., Gregori, L., Schemchel, D., Saunders, A.M., Roses, A.D., and Stritmatter, W.J. “Sequestration of amyloid beta peptide.” Annals of the New York Academy of Sciences, 695, 139-143, (1993).
  • Stritmatter, W.J., Huang, D.Y., Bhasin, R., Roses, A.D. and Goldgaber, D. “Avid binding of beta amyloid to it’s own precursor.” Exp. Neurol. 122(2), 327-334, (1993).


Previous Organizations & Titles
  • Private Practice in Endocrinology
  • Contract Physician, VA
  • Contract Physician, Emergency Room, VA